Amarjot Kaur

Amarjot Kaur is an Indian statistician who, in 2016, became the president of the International Indian Statistical Association. She works for Merck Research Laboratories,^[1] as Executive Director of Clinical Biostatistics and Research Decision Sciences.^[2] She is also the 2017 treasurer of the American Statistical Association,^[3] and in 2013 she chaired the American Statistical Association Community of Applied Statisticians.^[4]

Before joining Merck, Kaur earned her Ph.D. at Panjab University in Chandigarh, India,^[5] where she also worked as a lecturer.^[2] At Panjab, in the 1990s, Kaur published research in mathematical statistics on tests for stochastic dominance.^[T2O] She joined Merck after postdoctoral research at Pennsylvania State University.^[2] At Merck, she became the chief statistician on the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme, a large international study of treatments for arthritis.^[CVO]

In 2014, she was elected to be a Fellow of the American Statistical Association.^[6] In 2023 Kaur was the recipient of the American Statistical Association's Founders Award.^[7]